Dogwood Therapeutics, Inc. (DWTX) vs eXoZymes, Inc. (EXOZ)

A side-by-side comparison of Dogwood Therapeutics, Inc. and eXoZymes, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Dogwood Therapeutics, Inc. logo
DWTX
Dogwood Therapeutics, Inc.
$52M
$1.56HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
eXoZymes, Inc. logo
EXOZ
eXoZymes, Inc.
$51M
$5.54HealthcareDelayed quote: Oct 6, 2026, 1:04 PM EDT

Total return — DWTX vs EXOZ

growth of $100 · dividends reinvested · last 2y
DWTX -48.8% (-28.5%/yr)EXOZ -36.2% (-20.1%/yr)EXOZ compounded faster over this window
200400600Start $10020252026$51$64
DWTX EXOZ

DWTX vs EXOZ: by the numbers

  • •DWTX is the larger company ($52M vs $51M market cap).

Metrics side by side

Valuation

MetricDWTXEXOZ
P/B ratio0.7714.07

Profitability

MetricDWTXEXOZ
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-52.72%-278.89%
ROIC-38.04%-157.40%

Growth (annualized)

MetricDWTXEXOZ
Total return CAGR (5Y)-58.44%N/A

Go deeper

Full DWTX analysisFull EXOZ analysisInteractive comparison tool

Dig into the metrics

Dogwood Therapeutics ROEeXoZymes ROEDogwood Therapeutics operating margineXoZymes operating marginDogwood Therapeutics revenue growtheXoZymes revenue growthDogwood Therapeutics free cash floweXoZymes free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.